Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Generic Information: Tixepa (Tirzepatide) — Drug International Limited, Bangladesh

Tixepa is the tirzepatide injection of Drug International Limited (DIL), the Dhaka-headquartered manufacturer that also markets this molecule's relatives across its export portfolio. The official Tixepa insert lists exactly two presentations, both multi-dose prefilled pens of 2 mL total volume: Tixepa-5, containing 20 mg tirzepatide in 2 mL, and Tixepa-7.5, containing 30 mg in 2 mL. Each pen holds four weekly 0.5 mL doses — the "5" and "7.5" in the brand name refer to the per-dose strength, while 20 mg and 30 mg are the total drug content of the whole pen. This is a genuine Bangladesh generic benchmarked against the originator molecule, and it should not be confused with the single-dose six-strength ladder of the originator's US pens.

What Is Tixepa (Tirzepatide) Used For?

Tixepa is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The same insert extends the indication to chronic obesity, defined as a BMI of 30 kg/m² or greater, and to overweight — BMI of 27 kg/m² or greater — when at least one weight-related comorbidity such as hypertension, cardiovascular disease, type 2 diabetes, dyslipidemia or obstructive sleep apnea is present. Two boundaries are printed clearly: it has not been studied in people with a history of pancreatitis, and it is not for type 1 diabetes.

How Does Tixepa (Tirzepatide) Work?

The active ingredient is a 39-amino-acid modified peptide carrying a C20 fatty-diacid side chain that binds albumin and stretches the half-life to once-weekly dosing. It activates both the GIP receptor and the GLP-1 receptor — the natural targets of two incretin hormones — enhancing first- and second-phase insulin secretion and lowering glucagon in a strictly glucose-dependent way. The practical result is improved post-meal and fasting glucose with a reduced drive to overeat, delivered through a pen that is refrigerated between uses.

Indications of Tixepa (Bangladesh Label)

The Bangladesh label mirrors the originator's dual scope: type 2 diabetes for glycemic control, and weight management in obesity or overweight with a weight-related condition. It is positioned as a once-weekly option for patients who have not reached target on oral agents, and as a metabolic treatment for obesity that sits alongside structured lifestyle intervention. As with all tirzepatide products, the label excludes type 1 diabetes and cautions against use where pancreatitis is in the history.

Dosage and Administration

Tixepa is injected subcutaneously once weekly in the abdomen, thigh or upper arm, at any time of day and with or without meals, with the site rotated each week. The starting dose is 2.5 mg weekly for treatment initiation; after four weeks it rises to 5 mg weekly, then in 2.5 mg steps after at least four weeks on each dose as needed, to a maximum of 15 mg weekly. Because the pen delivers four 0.5 mL doses, a 5 mg weekly course draws the Tixepa-5 pen, and a 7.5 mg course the Tixepa-7.5 pen. A missed dose within four days is given as soon as possible; beyond four days it is skipped and the regular weekly schedule resumes, keeping at least three days between any two injections.

Side Effects of Tixepa

The most frequent side effects are gastrointestinal — nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia and abdominal pain — strongest during dose escalation and easing over time. The warnings match the class: a boxed risk of medullary thyroid carcinoma and MEN 2 (both contraindicated), pancreatitis, gallbladder disease and gallstones, hypoglycemia especially with insulin or sulfonylureas, hypersensitivity reactions, and monitoring of kidney function in patients with renal impairment who develop severe gastrointestinal symptoms. Diabetic retinopathy should be watched for progression during treatment.

Storage Instructions

Store unopened Tixepa pens in a refrigerator at 2°C to 8°C, protected from light and never frozen; discard a pen that has been frozen. Once a pen is in use it follows the in-use window printed on the leaflet and carton. Keep all pens out of the reach of children, and check the expiry date before starting a course.

Why Choose Tixepa from GLT?

Tixepa is the value option for buyers who want the originator's dual-incretin mechanism at Bangladesh generic economics, without sacrificing the once-weekly multi-dose convenience. GLT sources sealed DIL stock with the manufacturer's batch documentation, photographs each carton before dispatch, and quotes Tixepa alongside the originator and the other Bangladesh generic so the total landed cost — pen, shipping and paperwork — is transparent before ordering. A real person is reachable on WhatsApp +86 15234153837 or at [email protected] through quotation and delivery.

How to Order Tixepa (Tirzepatide)

Tell GLT which pen (Tixepa-5 or Tixepa-7.5), the quantity and the destination country via WhatsApp +86 15234153837 or [email protected]. A formal quotation with courier and payment options comes back, usually within a working day, and confirmed orders ship cold-chain with export paperwork. Multi-month courses can be scheduled ahead so the weekly rhythm never lapses.

FAQ

What does "Tixepa-5" mean — 5 mg or 20 mg? Both, correctly understood: the pen's per-dose strength is 5 mg, delivered as four 0.5 mL doses, so the total drug content is 20 mg in 2 mL. Tixepa-7.5 is 30 mg in 2 mL as four 7.5 mg doses.

Is Tixepa the same as Mounjaro? Same active ingredient, tirzepatide, but a Bangladesh generic with only two multi-dose pen strengths rather than the originator's wider single- and multi-dose ladder.

How many weeks does one pen last? Four weeks — each pen holds four weekly doses and is then discarded; it is a single-patient device and must not be shared.

Can I start directly on the 7.5 mg pen? The label starts everyone at 2.5 mg weekly and titrates upward after at least four weeks, so the higher-dose pen is reached only after the 5 mg step.

Does it need a prescription? Yes — tirzepatide is a prescription medicine, and a clinician should confirm the indication, rule out MTC or MEN 2, and supervise titration.